Reduced DNA topoisomerase II in VP-16 resistant mouse breast cancer cell line

This publication has 12 references indexed in Scilit:

• Isolation and characterization of VP-16 resistant human leukemia cell line
  Biomedicine & Pharmacotherapy, 1990
• DIRECT CORRELATION BETWEEN DNA TOPOISOMERASE-II ACTIVITY AND CYTO-TOXICITY IN ADRIAMYCIN-SENSITIVE AND ADRIAMYCIN-RESISTANT P388 LEUKEMIA-CELL LINES
  1989
• COMBINED MODALITIES OF RESISTANCE IN ETOPOSIDE-RESISTANT HUMAN KB-CELL LINES
  1988
• DNA STRAND BREAKS PRODUCED BY ETOPOSIDE (VP-16,213) IN SENSITIVE AND RESISTANT HUMAN-BREAST TUMOR-CELLS - IMPLICATIONS FOR THE MECHANISM OF ACTION
  1988
• Cross-resistance of novobiocin-resistant BHK cell line to topoisomerase II inhibitors
  Somatic Cell and Molecular Genetics, 1988
• RESISTANCE OF HUMAN-LEUKEMIC AND NORMAL LYMPHOCYTES TO DRUG-INDUCED DNA CLEAVAGE AND LOW-LEVELS OF DNA TOPOISOMERASE-II
  1988
• Inhibitors of DNA topoisomerases
  Biochemistry, 1988
• Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
  Journal of Biological Chemistry, 1984
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
  Proceedings of the National Academy of Sciences, 1984
• PROTEIN-ASSOCIATED DNA BREAKS AND DNA-PROTEIN CROSS-LINKS CAUSED BY DNA NONBINDING DERIVATIVES OF ADRIAMYCIN IN L1210 CELLS
  1981